Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, Lancet Oncol, vol.10, issue.5, pp.459-66, 2009. ,
Using the molecular classification of glioblastoma to inform personalized treatment, J Pathol, vol.232, issue.2, pp.165-77, 2014. ,
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis, Cancer Cell, vol.9, issue.3, pp.157-73, 2006. ,
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1, Cancer Cell, vol.17, issue.1, pp.98-110, 2010. ,
Tumor evolution of glioma intrinsic gene expression subtype associates with immunological changes in the microenvironment, Cancer Cell, vol.32, issue.1, pp.42-56, 2017. ,
Targeting metabolism to induce cell death in cancer cells and cancer stem cells, Int J Cell Biol, vol.2013, pp.1-13, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02447021
The cancer stem cell: premises, promises and challenges, Nat Med, vol.17, issue.3, pp.313-322, 2011. ,
Cancer stem cells: the challenges ahead, Nat Cell Biol, vol.15, issue.4, pp.338-382, 2013. ,
Efficient mitochondrial glutamine targeting prevails over glioblastoma metabolic plasticity, Clin Cancer Res Off J Am Assoc Cancer Res, vol.23, issue.20, pp.6292-304, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01595798
Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo, Cell Metab, vol.15, issue.6, pp.827-864, 2012. ,
An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation, p.60012, 2016. ,
D-2-Hydroxyglutarate does not mimic all the IDH mutation effects, in particular the reduced etoposide-triggered apoptosis mediated by an alteration in mitochondrial NADH, Cell Death Dis, vol.6, p.1704, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01818661
A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue, Nat Protoc, vol.7, issue.5, pp.872-81, 2012. ,
Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma, Nat Cell Biol, vol.17, issue.12, pp.1556-68, 2015. ,
Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma, Cancer Cell, vol.22, issue.4, pp.547-60, 2012. ,
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo, Sci Transl Med, vol.7, issue.274, pp.274-291, 2015. ,
Targeting glutamine metabolism and redox state for leukemia therapy, Clin Cancer Res Off J Am Assoc Cancer Res, vol.25, issue.13, pp.4079-90, 2019. ,
Targeting mitochondrial glutaminase activity inhibits oncogenic transformation, Cancer Cell, vol.18, issue.3, pp.207-226, 2010. ,
Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer, Mol Cancer Ther, vol.13, issue.4, pp.890-901, 2014. ,
Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1, Cancer Res, vol.70, issue.22, pp.8981-8988, 2010. ,
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia, Nature, 2011. ,
Vander Heiden MG. Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition, vol.15, p.6, 2017. ,
Metabolism shapes the tumor microenvironment, Curr Opin Cell Biol, vol.48, pp.47-53, 2017. ,
Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer, Cell Metab, vol.23, issue.3, pp.517-545, 2016. ,
Metabolic control of epigenetics in cancer, Nat Rev Cancer, vol.16, issue.11, pp.694-707, 2016. ,
Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity, J Clin Oncol Off J Am Soc Clin Oncol, vol.26, issue.25, pp.4189-99, 2008. ,
Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme, J Clin Oncol Off J Am Soc Clin Oncol, vol.29, issue.2, pp.142-150, 2011. ,
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma, J Clin Oncol Off J Am Soc Clin Oncol, vol.27, issue.28, pp.4733-4773, 2009. ,
Targeting glioma stem cells through combined BMI1 and EZH2 inhibition, Nat Med, vol.23, issue.11, pp.1352-61, 2017. ,
Cancer anabolic metabolism inhibitors move into clinic, Nat Biotechnol, vol.34, issue.8, pp.794-799, 2016. ,
Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects, Nat Commun, vol.9, issue.1, p.1208, 2018. ,
Control of glioma cell death and differentiation by PKM2-Oct4 interaction, Cell Death Dis, vol.5, p.1036, 2014. ,